Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nelson Hayes

Showing results (71-80 of 161) with videos related to

Pageof 17
Sort By:
International Journal of Molecular Sciences|October 29, 2025
Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B PatientsKeiichi Hiraoka, Masataka Tsuge, Michihiko Kawahara, et al.
Virus Research|November 17, 2015
Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric miceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.
Journal of Gastroenterology|January 12, 2013
Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in miceHisako Furusho, Mutsumi Miyauchi, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 31, 2016
IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis CNami Mori, Michio Imamura, Yoshiiku Kawakami, et al.
Plos One|October 24, 2012
Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycleC Nelson Hayes, Sakura Akamatsu, Masataka Tsuge, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 17, 2024
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinomaShinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami, et al.
The Journal of Infection|December 3, 2014
Differences in serum microRNA profiles in hepatitis B and C virus infectionSakura Akamatsu, C Nelson Hayes, Masataka Tsuge, et al.
The Journal of General Virology|February 1, 2017
Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virologyTakuro Uchida, Michio Imamura, Hiromi Kan, et al.
Nature Genetics|July 5, 2011
Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriersDaiki Miki, Hidenori Ochi, C Nelson Hayes, et al.
Plos One|September 3, 2011
Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouseMasataka Tsuge, Yoshifumi Fujimoto, Nobuhiko Hiraga, et al.
Pageof 17

Showing results (71-80 of 161) with videos related to

Sort By:
Pageof 17
International Journal of Molecular Sciences|October 29, 2025
Utility of Serum HBV RNA Measurement During Nucleoside/Nucleotide Analog Therapy in Chronic Hepatitis B PatientsKeiichi Hiraoka, Masataka Tsuge, Michihiko Kawahara, et al.
Virus Research|November 17, 2015
Elimination of HCV via a non-ISG-mediated mechanism by vaniprevir and BMS-788329 combination therapy in human hepatocyte chimeric miceTakuro Uchida, Nobuhiko Hiraga, Michio Imamura, et al.
Journal of Gastroenterology|January 12, 2013
Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in miceHisako Furusho, Mutsumi Miyauchi, Hideyuki Hyogo, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 31, 2016
IFNL4 polymorphism effects on outcome of simeprevir, peginterferon, and ribavirin therapy for older patients with genotype 1 chronic hepatitis CNami Mori, Michio Imamura, Yoshiiku Kawakami, et al.
Plos One|October 24, 2012
Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycleC Nelson Hayes, Sakura Akamatsu, Masataka Tsuge, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 17, 2024
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinomaShinsuke Uchikawa, Tomokazu Kawaoka, Serami Murakami, et al.
The Journal of Infection|December 3, 2014
Differences in serum microRNA profiles in hepatitis B and C virus infectionSakura Akamatsu, C Nelson Hayes, Masataka Tsuge, et al.
The Journal of General Virology|February 1, 2017
Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virologyTakuro Uchida, Michio Imamura, Hiromi Kan, et al.
Nature Genetics|July 5, 2011
Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriersDaiki Miki, Hidenori Ochi, C Nelson Hayes, et al.
Plos One|September 3, 2011
Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouseMasataka Tsuge, Yoshifumi Fujimoto, Nobuhiko Hiraga, et al.
Pageof 17